US Stock MarketDetailed Quotes

SNTI Senti Biosciences

Watchlist

2.2600
-0.0200-0.88%

Close Sep 27 16:00 ET

2.2600
0.00000.00%

Post 18:00 ET

10.35MMarket Cap-178P/E (TTM)

Senti Biosciences Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

38.98%-8.35M

28.35%-11.68M

-50.15%-52.4M

21.86%-7.04M

-51.73%-15.38M

-140.12%-13.68M

-62.08%-16.3M

-0.75%-34.9M

24.77%-9.01M

-15.12%-10.14M

Net income from continuing operations

40.08%-11.2M

35.31%-12.11M

-22.05%-71.06M

-2.60%-18.7M

10.19%-14.94M

-61.85%-18.7M

-58.55%-18.72M

-5.25%-58.22M

-67.11%-18.22M

-45.89%-16.64M

Operating gains losses

----

-1,596.04%-21.86M

--0

----

---1.29M

--0

Depreciation and amortization

21.14%1.47M

57.27%1.46M

38.49%5.43M

56.14%1.47M

76.04%1.82M

29.52%1.21M

-8.02%929K

30.23%3.92M

-8.70%944K

18.23%1.03M

Other non cash items

3,073.17%3.66M

-2,551.69%-2.36M

45.90%-5.2M

176.02%799K

-2,062.03%-5.79M

---123K

---89K

-165.21%-9.61M

---1.05M

--295K

Change In working capital

171.02%2.39M

104.34%70K

-66.45%4.67M

17.39%5.98M

-120.19%-583K

-84.97%880K

-2,543.94%-1.61M

2,160.81%13.9M

278.83%5.1M

163.99%2.89M

-Change in receivables

-183.42%-166K

115.56%21K

-609.16%-929K

401.72%1.16M

-690.11%-2.16M

239.16%199K

-354.72%-135K

66.84%-131K

564.00%232K

---273K

-Change in prepaid assets

948.26%4.21M

1,015.17%3.68M

468.20%4.79M

525.98%3.35M

410.75%1.45M

140.57%402K

-5.51%-402K

20.71%-1.3M

977.05%535K

42.02%-465K

-Change in payables and accrued expense

-266.94%-616K

-63.28%-2.56M

-80.99%426K

75.15%1.16M

-59.18%467K

-81.68%369K

0.70%-1.57M

14.51%2.24M

130.34%660K

-55.54%1.14M

-Change in other current liabilities

-742.48%-983K

-207.26%-946K

-96.57%484K

-87.53%370K

-128.64%-921K

-97.23%153K

-63.61%882K

1,342.66%14.13M

1,920.86%2.97M

1,407.32%3.22M

-Change in other working capital

73.66%-64K

67.60%-127K

89.35%-110K

-108.29%-58K

179.43%583K

55.49%-243K

13.47%-392K

-156.39%-1.03M

275.00%700K

-70.30%-734K

Cash from discontinued investing activities

Operating cash flow

38.98%-8.35M

28.35%-11.68M

-50.15%-52.4M

21.86%-7.04M

-51.73%-15.38M

-140.12%-13.68M

-62.08%-16.3M

-0.75%-34.9M

24.77%-9.01M

-15.12%-10.14M

Investing cash flow

Cash flow from continuing investing activities

99.84%-15K

136.70%30.08M

100.21%101K

248.88%21.14M

262.80%18.33M

-28.69%-9.5M

-1,378.60%-81.96M

-1,132.57%-49.12M

-1,423.71%-14.2M

Net PPE purchase and sale

--0

99.77%-15K

71.16%-11.93M

101.18%101K

86.92%-1.86M

67.42%-3.67M

11.83%-6.51M

-646.42%-41.37M

-114.13%-8.53M

-1,423.71%-14.2M

Net investment purchase and sale

--0

203.51%42.01M

--0

--23M

--22M

---2.99M

---40.59M

--0

Cash from discontinued investing activities

Investing cash flow

--0

99.84%-15K

136.70%30.08M

100.21%101K

248.88%21.14M

262.80%18.33M

-28.69%-9.5M

-1,378.60%-81.96M

-1,132.57%-49.12M

-1,423.71%-14.2M

Financing cash flow

Cash flow from continuing financing activities

-99.34%779K

-36.53%556K

95.26%-23K

-99.76%281K

92.31%-35K

73.23%118.55M

3,708.70%876K

-199.59%-485K

Net issuance payments of debt

--0

-102.09%-108K

---23K

-100.52%-27K

---35K

--5.18M

--0

Net common stock issuance

----

-29.67%512K

----

--728K

----

Proceeds from stock option exercised by employees

----

-44.20%375K

-55.63%67K

--0

----

-55.20%672K

277.50%151K

--0

Net other financing activities

----

658,782.35%111.98M

---3K

---485K

Cash from discontinued financing activities

Financing cash flow

--0

-99.34%779K

-36.53%556K

95.26%-23K

-99.76%281K

92.31%-35K

73.23%118.55M

3,708.70%876K

-199.59%-485K

Net cash flow

Beginning cash position

-21.05%27.75M

-35.32%39.45M

2.86%60.99M

-61.24%45.83M

-71.98%40.09M

-15.09%35.15M

2.86%60.99M

91.05%59.29M

57.18%118.24M

69.35%143.06M

Current changes in cash

-269.03%-8.35M

54.73%-11.7M

-1,369.99%-21.54M

88.86%-6.38M

123.12%5.74M

-95.14%4.94M

-44.38%-25.84M

-94.00%1.7M

-259.30%-57.25M

-168.35%-24.82M

End cash Position

-51.59%19.41M

-21.05%27.75M

-35.32%39.45M

-61.24%45.83M

-71.98%40.09M

-15.09%35.15M

2.86%60.99M

57.18%118.24M

Free cash flow

51.89%-8.35M

48.72%-11.7M

15.52%-64.43M

59.86%-7.04M

29.17%-17.24M

-2.29%-17.34M

-30.80%-22.81M

-89.83%-76.27M

-9.92%-17.54M

-149.94%-24.34M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	38.98%-8.35M	28.35%-11.68M	-50.15%-52.4M	21.86%-7.04M	-51.73%-15.38M	-140.12%-13.68M	-62.08%-16.3M	-0.75%-34.9M	24.77%-9.01M	-15.12%-10.14M
Net income from continuing operations	40.08%-11.2M	35.31%-12.11M	-22.05%-71.06M	-2.60%-18.7M	10.19%-14.94M	-61.85%-18.7M	-58.55%-18.72M	-5.25%-58.22M	-67.11%-18.22M	-45.89%-16.64M
Operating gains losses	----	----	-1,596.04%-21.86M	--0	----	----	----	---1.29M	--0	--0
Depreciation and amortization	21.14%1.47M	57.27%1.46M	38.49%5.43M	56.14%1.47M	76.04%1.82M	29.52%1.21M	-8.02%929K	30.23%3.92M	-8.70%944K	18.23%1.03M
Other non cash items	3,073.17%3.66M	-2,551.69%-2.36M	45.90%-5.2M	176.02%799K	-2,062.03%-5.79M	---123K	---89K	-165.21%-9.61M	---1.05M	--295K
Change In working capital	171.02%2.39M	104.34%70K	-66.45%4.67M	17.39%5.98M	-120.19%-583K	-84.97%880K	-2,543.94%-1.61M	2,160.81%13.9M	278.83%5.1M	163.99%2.89M
-Change in receivables	-183.42%-166K	115.56%21K	-609.16%-929K	401.72%1.16M	-690.11%-2.16M	239.16%199K	-354.72%-135K	66.84%-131K	564.00%232K	---273K
-Change in prepaid assets	948.26%4.21M	1,015.17%3.68M	468.20%4.79M	525.98%3.35M	410.75%1.45M	140.57%402K	-5.51%-402K	20.71%-1.3M	977.05%535K	42.02%-465K
-Change in payables and accrued expense	-266.94%-616K	-63.28%-2.56M	-80.99%426K	75.15%1.16M	-59.18%467K	-81.68%369K	0.70%-1.57M	14.51%2.24M	130.34%660K	-55.54%1.14M
-Change in other current liabilities	-742.48%-983K	-207.26%-946K	-96.57%484K	-87.53%370K	-128.64%-921K	-97.23%153K	-63.61%882K	1,342.66%14.13M	1,920.86%2.97M	1,407.32%3.22M
-Change in other working capital	73.66%-64K	67.60%-127K	89.35%-110K	-108.29%-58K	179.43%583K	55.49%-243K	13.47%-392K	-156.39%-1.03M	275.00%700K	-70.30%-734K
Cash from discontinued investing activities
Operating cash flow	38.98%-8.35M	28.35%-11.68M	-50.15%-52.4M	21.86%-7.04M	-51.73%-15.38M	-140.12%-13.68M	-62.08%-16.3M	-0.75%-34.9M	24.77%-9.01M	-15.12%-10.14M
Investing cash flow
Cash flow from continuing investing activities	0	99.84%-15K	136.70%30.08M	100.21%101K	248.88%21.14M	262.80%18.33M	-28.69%-9.5M	-1,378.60%-81.96M	-1,132.57%-49.12M	-1,423.71%-14.2M
Net PPE purchase and sale	--0	99.77%-15K	71.16%-11.93M	101.18%101K	86.92%-1.86M	67.42%-3.67M	11.83%-6.51M	-646.42%-41.37M	-114.13%-8.53M	-1,423.71%-14.2M
Net investment purchase and sale	--0	--0	203.51%42.01M	--0	--23M	--22M	---2.99M	---40.59M	---40.59M	--0
Cash from discontinued investing activities
Investing cash flow	--0	99.84%-15K	136.70%30.08M	100.21%101K	248.88%21.14M	262.80%18.33M	-28.69%-9.5M	-1,378.60%-81.96M	-1,132.57%-49.12M	-1,423.71%-14.2M
Financing cash flow
Cash flow from continuing financing activities	0	0	-99.34%779K	-36.53%556K	95.26%-23K	-99.76%281K	92.31%-35K	73.23%118.55M	3,708.70%876K	-199.59%-485K
Net issuance payments of debt	--0	--0	-102.09%-108K	---23K	---23K	-100.52%-27K	---35K	--5.18M	--0	--0
Net common stock issuance	----	----	-29.67%512K	----	----	----	----	--728K	----	----
Proceeds from stock option exercised by employees	----	----	-44.20%375K	-55.63%67K	--0	----	----	-55.20%672K	277.50%151K	--0
Net other financing activities	----	----	----	----	----	----	----	658,782.35%111.98M	---3K	---485K
Cash from discontinued financing activities
Financing cash flow	--0	--0	-99.34%779K	-36.53%556K	95.26%-23K	-99.76%281K	92.31%-35K	73.23%118.55M	3,708.70%876K	-199.59%-485K
Net cash flow
Beginning cash position	-21.05%27.75M	-35.32%39.45M	2.86%60.99M	-61.24%45.83M	-71.98%40.09M	-15.09%35.15M	2.86%60.99M	91.05%59.29M	57.18%118.24M	69.35%143.06M
Current changes in cash	-269.03%-8.35M	54.73%-11.7M	-1,369.99%-21.54M	88.86%-6.38M	123.12%5.74M	-95.14%4.94M	-44.38%-25.84M	-94.00%1.7M	-259.30%-57.25M	-168.35%-24.82M
End cash Position	-51.59%19.41M	-21.05%27.75M	-35.32%39.45M	-35.32%39.45M	-61.24%45.83M	-71.98%40.09M	-15.09%35.15M	2.86%60.99M	2.86%60.99M	57.18%118.24M
Free cash flow	51.89%-8.35M	48.72%-11.7M	15.52%-64.43M	59.86%-7.04M	29.17%-17.24M	-2.29%-17.34M	-30.80%-22.81M	-89.83%-76.27M	-9.92%-17.54M	-149.94%-24.34M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	Unqualified Opinion with Explanatory Notes	--	--	--	--	Unqualified Opinion with Explanatory Notes	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data